Xylazine Associated Wound Care-Recording - Xylazine Associated Wound Care

Video Transcription

Video Summary

Dr. Ragini Jawa’s presentation explains xylosine-associated wounds, a growing complication of the unregulated opioid supply. Xylosine is a veterinary sedative not approved for human use, often mixed with opioids and linked to painful, necrotic wounds that can begin as purple or blister-like lesions and progress to ulcers, infection, and even amputation. These wounds can occur regardless of drug route or injection site and are distinct from ordinary skin and soft tissue infections.<br /><br />The talk emphasizes harm-reduction, trauma-informed wound care: gentle cleansing with soap and water or saline, keeping wounds covered, avoiding harsh products like alcohol or hydrogen peroxide, and using appropriate dressings and ointments to maintain moisture and promote healing. It also highlights the importance of pain control, withdrawal management, and avoiding unnecessary antibiotics for noninfected wounds.<br /><br />Dr. Jawa reviews research showing that many patients self-treat their wounds, often without adequate supplies, and that stigma and poor pain management in hospitals can lead to care interruptions. She advocates for low-barrier wound care integrated into addiction services, community syringe programs, and multidisciplinary hospital protocols. The key message: xylosine wounds can heal when patients have access to compassionate care, supplies, and coordinated addiction and wound treatment.

Keywords

xylosine-associated wounds

opioid supply contamination

necrotic skin lesions

harm-reduction wound care

trauma-informed care

pain management

withdrawal management

low-barrier wound care

addiction services